Revlimid, pomalyst, camzyos specialty pharmaceuticals
Active Awarded
- Contract number
- 36C25226N0198
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $848,445
Award facts
- Contract value 100% obligated
- $848,445.00 Current and potential, with all options
- Completion date 96% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lawrenceville, Lawrence Township, NJ 08648, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company has been awarded a delivery order valued at $848,445 by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 12, for the supply of specialty pharmaceuticals including Revlimid, Pomalyst, and Camzyos. This firm fixed-price delivery order, issued on December 31, 2025, with an ultimate completion date of October 31, 2026, represents a child contract under Bristol-Myers Squibb's existing Federal Supply Schedule (FSS-61-IB) Pharmaceuticals and Drugs master contract with the VA. The master contract, which extends through April 30, 2029, carries a substantial ceiling value of approximately $12.3 billion and enables the VA to procure a comprehensive range of pharmaceutical products with particular emphasis on oncology and immunotherapy treatments. No set-aside designation was applied to this delivery order, consistent with Bristol-Myers Squibb's status as a large pharmaceutical manufacturer.
The award supports the VA's mission to deliver advanced medical treatments to eligible veterans, leveraging Bristol-Myers Squibb's specialized expertise in innovative cancer therapies and cell-based treatments. The contractor's Lawrenceville, New Jersey facility will serve as the place of performance for this delivery order. Bristol-Myers Squibb's extensive portfolio of federal contract awards through the VA demonstrates its critical role in providing cutting-edge pharmaceutical solutions across multiple Veterans Integrated Service Networks, ensuring veteran access to advanced oncology and immunotherapy options that represent the current standard of care in cancer treatment.
Quick answers
Who was awarded contract 36C25226N0198?
36C25226N0198 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 12 (Veterans Health Administration) on December 31, 2025.
How much is contract 36C25226N0198 worth?
The government has obligated $848,445 on 36C25226N0198.
Is contract 36C25226N0198 an order under another contract?
Yes. 36C25226N0198 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25226N0198 competed?
The extent of competition for 36C25226N0198 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award